|
Volumn 71, Issue 9, 2002, Pages 1005-1014
|
VIP-ellipticine derivatives inhibit the growth of breast cancer cells
|
Author keywords
Breast cancer; VIP agonists; VIP ellipticine derivatives; VPAC1 receptor
|
Indexed keywords
CYCLIC AMP;
ELLIPTICINE DERIVATIVE;
MESSENGER RNA;
METHIONINE;
PROTEIN C FOS;
TRYPTOPHAN;
VASOACTIVE INTESTINAL POLYPEPTIDE DERIVATIVE;
ARTICLE;
BREAST CARCINOMA;
CANCER CELL CULTURE;
CANCER INHIBITION;
CELL CLONING;
CELL VIABILITY;
CONCENTRATION RESPONSE;
CONTROLLED STUDY;
DRUG EFFECT;
GENE EXPRESSION REGULATION;
HUMAN;
HUMAN CELL;
IC 50;
ISOTOPE LABELING;
AMINO ACID SEQUENCE;
BREAST NEOPLASMS;
CELL DIVISION;
ELLIPTICINES;
HUMANS;
MOLECULAR SEQUENCE DATA;
PROTO-ONCOGENE PROTEINS C-FOS;
RECEPTORS, VASOACTIVE INTESTINAL PEPTIDE;
RECEPTORS, VASOACTIVE INTESTINAL POLYPEPTIDE, TYPE I;
RNA, MESSENGER;
VASOACTIVE INTESTINAL PEPTIDE;
MINK CELL FOCUS-FORMING VIRUS;
|
EID: 0037135257
PISSN: 00243205
EISSN: None
Source Type: Journal
DOI: 10.1016/S0024-3205(02)01741-1 Document Type: Article |
Times cited : (38)
|
References (23)
|